Phoenix-based Dot Compliance, which provides an AI-powered quality management system for compliance, announced it closed $17.5 million in Series B extension funding, bringing its total funding to $50 million.
The funding round was led by existing investors IGP Capital and Vertex Ventures with additional investment from TPY Capital.
WHAT IT DOES
Dot Compliance AI solutions provide a vendor-...
Cambridge, Massachusetts-based Vitality announced the commercial availability of its wireless Internet-enabled pill caps product, GlowCaps, which fit popular prescription bottles and help remind people to take their medications on time. GlowCaps are now available on Amazon.com for $99.
As the name suggests, GlowCaps use light and sound to signal when it is time to take medications, the product...
During a plenary session at the American Telemedicine Association event in Las Vegas this week Colonel Jeffrey Davies, Acting Commander of the U.S. Army Medical Research and Materiel Command described an mHealth project for wounded soldiers who have recently returned home from conflicts overseas. Davies' talk was entitled "The Army Medical Department's Tele-TBI Intitiatives: Today Military...
Novartis CEO and Chairman Daniel Vasella said that technology solutions do not do an adequate job of solving the medical adherence and compliance problem that faces the healthcare and pharmaceutical industries.
Internet programs that provide feedback loops to patients, instruments that can measure biometrics and transmit the data to caregivers, and new pill bottles that can remind you (by text...
By Carmen R. Gonzalez, Manager of Strategy and Communications, HCG
When it comes to successfully completing clinical studies, keeping patients enrolled is crucial. Lengthy trials pose a significant risk of patients dropping out, especially if invasive procedures are involved. In studies that include add-on trials, every patient's continued participation grows even more valuable. In addition,...
According to a report from Signs of the Times, "two major drugs companies" in the UK are set to begin clinical trials of Proteus Biomedical's wireless pill technology, Raisin. Trials will reportedly commence within the next 12 months.
Imperial College London cardiologist and professor Nick Peters will coordinate the trials.
"This is all about empowering patients and their families because it...
Thanks to the focus on mHealth at the CTIA show in Las Vegas this week, a number of bigger players are opening up about their plans to launch mHealth services in the year ahead. Great Call's Jitterbug phone service for the less tech-savvy older demographic (and anyone else looking for a very, very simple user interface) told Wireless Week that it has firm plans in place for a medication adherence...
This morning at the CTIA wireless event in Las Vegas, CTIA President Steve Largent announced the latest metrics for mobile phone usage in the U.S. The numbers only reaffirm the mobile platform as the best one for interactive health applications. Here's a quick rundown of the latest wireless stats for U.S. subscribers:
Subscribers: The total number of subscribers at the end of 2008 was more than...
A recent reader comment about SMS security and reliability issues, dovetails nicely with the presentation that Barbara Rapchak, CEO of Leap of Faith Technologies gave last week at the TEPR conference in Palm Springs. Her company conducted a medicine compliance pilot study that sent text messages reminding users to take their medication on-time--but the texts were not sent over a wireless carrier'...
WellDoc's Vice President of Healthcare Integration Malinda Peeples outlined the company's ongoing pilot of a mobile phone-based diabetes monitoring system, that is partially funded by LifeScan and Sprint. Peeples noted the opportunities for mHealth in endocrinology and diabetes in particular by pointing to the 21 million Americans currently living with diabetes, the 54 million "pre-diabetic"...
